[Metformin and type-2 diabetes mellitus].
作者信息
Mata Cases Manel
机构信息
Centro de Atención Primaria La Mina, Institut Català de la Salut,SAP Litoral, Sant Adrià de Besòs, Barcelona, España.
出版信息
Aten Primaria. 2008 Mar;40(3):147-53. doi: 10.1157/13116631.
Abstract
摘要
相似文献
1
[Metformin and type-2 diabetes mellitus].
Aten Primaria. 2008 Mar;40(3):147-53. doi: 10.1157/13116631.
2
Summaries for patients. Metformin for patients with type 2 diabetes mellitus.
Ann Intern Med. 2002 Jul 2;137(1):I50. doi: 10.7326/0003-4819-137-1-200207020-00004.
3
Metformin in 2019.
JAMA. 2019 May 21;321(19):1926-1927. doi: 10.1001/jama.2019.3805.
4
Metformin: diamonds are forever.
Expert Opin Pharmacother. 2009 Oct;10(15):2395-7. doi: 10.1517/14656560903176453.
5
Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Pregnancy-Reply.
JAMA. 2024 May 7;331(17):1502. doi: 10.1001/jama.2024.1383.
6
Metformin.
N Engl J Med. 1996 Feb 29;334(9):574-9. doi: 10.1056/NEJM199602293340906.
7
Metformin in noninsulin-dependent diabetes mellitus.
Pharmacotherapy. 1996 May-Jun;16(3):327-51.
8
Metformin: a review.
Drugs Today (Barc). 2008 Apr;44(4):303-14. doi: 10.1358/dot.2008.44.4.1138124.
9
Role of metformin in type II diabetes.
Cleve Clin J Med. 1995 Sep-Oct;62(5):278-9. doi: 10.3949/ccjm.62.5.278.
10
Metformin: a biguanide.
Diabetes Educ. 1995 Nov-Dec;21(6):509-10, 513-4.
引用本文的文献
1
[Metformin also as first choice in patients with normal weight. Has its use increased?].
Aten Primaria. 2009 Jun;41(6):324-8. doi: 10.1016/j.aprim.2008.10.010. Epub 2009 May 21.
本文引用的文献
1
Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?
BMJ. 2007 Sep 8;335(7618):508-12. doi: 10.1136/bmj.39255.669444.AE.
2
Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.
Diabet Med. 2007 Oct;24(10):1160-3. doi: 10.1111/j.1464-5491.2007.02221.x. Epub 2007 Aug 2.
3
Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.
Diabet Med. 2007 May;24(5):494-7. doi: 10.1111/j.1464-5491.2007.02118.x. Epub 2007 Mar 15.
4
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
N Engl J Med. 2006 Dec 7;355(23):2427-43. doi: 10.1056/NEJMoa066224. Epub 2006 Dec 4.
5
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes Care. 2006 Aug;29(8):1963-72. doi: 10.2337/dc06-9912.
6
Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.
Diabet Med. 2006 Jun;23(6):579-93. doi: 10.1111/j.1464-5491.2006.01918.x.
7
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.
Diabetologia. 2006 May;49(5):930-6. doi: 10.1007/s00125-006-0176-9. Epub 2006 Mar 9.
8
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD002967. doi: 10.1002/14651858.CD002967.pub2.
9
Contraindications can damage your health--is metformin a case in point?
Diabetologia. 2005 Dec;48(12):2454-9. doi: 10.1007/s00125-005-0026-1. Epub 2005 Nov 11.
10
Metformin and heart failure: innocent until proven guilty.
Diabetes Care. 2005 Oct;28(10):2585-7. doi: 10.2337/diacare.28.10.2585.
Zotero 插件